Dimer-tetramer transition controls RUNX1/ETO leukemogenic activity.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Blood

• Publication date

  2010-07-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2009-10-248047PMID 20430957
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transforming activity of AML1-ETO is independent of CBFβ and ETO interaction but requires formation of homo-oligomeric complexes

  2009cited by this paper
• Disruption of the NHR4 domain structure in AML1-ETO abrogates SON binding and promotes leukemogenesis

  2008cited by this paper
• Optimized Retroviral Transduction Protocol Which Preserves the Primitive Subpopulation of Human Hematopoietic Cells

  2008cited by this paper
• PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis

  2008cited by this paper
• AML1/ETO Oncoprotein Is Directed to AML1 Binding Regions and Co-Localizes with AML1 and HEB on Its Targets

  2008cited by this paper
• Transcriptional repression of the RUNX3/AML2 gene by the t(8;21) and inv(16) fusion proteins in acute myeloid leukemia.

  2008cited by this paper
• Configurational entropy elucidates the role of salt‐bridge networks in protein thermostability

  2007cited by this paper
• Targeting the oligomerization domain of ETO interferes with RUNX1/ETO oncogenic activity in t(8;21)-positive leukemic cells.

  2007cited by this paper
• Targeting protein-protein interactions with small molecules: challenges and perspectives for computational binding epitope detection and ligand finding.

  2006cited by this paper
• The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activity.

  2006influential reference
• A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis

  2006cited by this paper
• RUNX1/AML1 DNA-binding domain and ETO/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesis.

  2006cited by this paper
• The Amber biomolecular simulation programs

  2005cited by this paper
• Stat5 tetramer formation is associated with leukemogenesis.

  2005cited by this paper
• Magnitude of the hydrophobic effect at central versus peripheral sites in protein-protein interfaces.

  2005cited by this paper
• ETO interacting proteins

  2004cited by this paper
• Dimerization: a versatile switch for oncogenesis.

  2004cited by this paper
• The Nuclear Receptor Co-repressor (N-CoR) Utilizes Repression Domains I and III for Interaction and Co-repression with ETO*

  2004cited by this paper
• E Protein Silencing by the Leukemogenic AML1-ETO Fusion Protein

  2004cited by this paper
• Deletion of an AML1-ETO C-terminal NcoR/SMRT-interacting region strongly induces leukemia development.

  2004influential reference
• Small-molecule inhibitors of protein–protein interactions: progressing towards the dream

  2004cited by this paper
• Fragment-based drug discovery.

  2004cited by this paper
• Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia

  2004cited by this paper
• Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes.

  2003cited by this paper
• Disruption of differentiation in human cancer: AML shows the way

  2003cited by this paper
• Binding of small molecules to an adaptive protein–protein interface

  2003cited by this paper
• AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells.

  2003cited by this paper
• Inhibition of protein-protein association by small molecules: approaches and progress.

  2002cited by this paper
• Size-distribution analysis of proteins by analytical ultracentrifugation: strategies and application to model systems.

  2002cited by this paper
• Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia.

  2002cited by this paper
• Structure of the Bcr-Abl oncoprotein oligomerization domain

  2002cited by this paper
• The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells.

  2002cited by this paper
• All-atom structure prediction and folding simulations of a stable protein.

  2002cited by this paper
• Cooperative function of Aml1-ETO corepressor recruitment domains in the expansion of primary bone marrow cells.

  2002cited by this paper
• Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta.

  2001cited by this paper
• Multiple Regions of ETO Cooperate in Transcriptional Repression*

  2001cited by this paper
• Binding free energies and free energy components from molecular dynamics and Poisson-Boltzmann calculations. Application to amino acid recognition by aspartyl-tRNA synthetase.

  2001cited by this paper
• Dichotomy of AML1-ETO Functions: Growth Arrest versus Block of Differentiation

  2001cited by this paper
• The leukemia-associated AML1 (Runx1)–CBFβ complex functions as a DNA-induced molecular clamp

  2001cited by this paper
• Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model.

  2000cited by this paper
• Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling.

  2000cited by this paper
• Peptide and protein recognition by designed molecules.

  2000cited by this paper
• Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation.

  2000cited by this paper
• Energetic and Functional Contribution of Residues in the Core Binding Factor β (CBFβ) Subunit to Heterodimerization with CBFα*

  2000cited by this paper
• Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers.

  2000cited by this paper
• Biophysical characterization of interactions between the core binding factor α and β subunits and DNA

  2000cited by this paper
• Biophysical characterization of interactions between the core binding factor alpha and beta subunits and DNA.

  2000cited by this paper
• Electrostatic interactions in the GCN4 leucine zipper: Substantial contributions arise from intramolecular interactions enhanced on binding

  1999cited by this paper
• ETO, a Target of t(8;21) in Acute Leukemia, Interacts with the N-CoR and mSin3 Corepressors

  1998cited by this paper
• Anatomy of hot spots in protein interfaces.

  1998cited by this paper
• Oncogenic transcription factors in the human acute leukemias.

  1997cited by this paper
• A hot spot of binding energy in a hormone-receptor interface

  1995cited by this paper
• A second generation force field for the simulation of proteins

  1995cited by this paper

• Identification of non-charged 7.44 analogs interacting with the NHR2 domain of RUNX1-ETO with improved antiproliferative effect in RUNX-ETO positive cells

  2025influential citation
• The role of multivalency in the association of the eight twenty-one protein 2 (ETO2) with the nucleosome remodeling and deacetylase (NuRD) complex

  2025cites this paper
• Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytes

  2024cites this paper
• Identification of non-charged 7.44 analogs interacting with the NHR2 domain of RUNX1-ETO and exhibiting an improved, selective antiproliferative effect in RUNX-ETO positive cells

  2024cites this paper
• Defined Human Leukemic CD34+ Liquid Cultures to Study HDAC/Transcriptional Repressor Complexes.

  2023cites this paper
• Biophysical and pharmacokinetic characterization of a small-molecule inhibitor of RUNX1/ETO tetramerization with anti-leukemic effects

  2021cites this paper
• Reduction of RUNX1 transcription factor activity by a CBFA2T3-mimicking peptide: application to B cell precursor acute lymphoblastic leukemia

  2021cites this paper
• t(8;21) Acute Myeloid Leukemia as a Paradigm for the Understanding of Leukemogenesis at the Level of Gene Regulation and Chromatin Programming

  2020cites this paper
• Human erythroleukemia genetics and transcriptomes identify master transcription factors as functional disease drivers.

  2020cites this paper
• Role of GFI1 in Epigenetic Regulation of MDS and AML Pathogenesis: Mechanisms and Therapeutic Implications

  2019cites this paper
• A Rare Case of Acute Myeloblastic Leukemia With Blast Count Less Than 20% in Bone Marrow

  2019cites this paper
• GFI1 is required for RUNX1/ETO positive acute myeloid leukemia

  2018influential citation
• Compatibility of RUNX1/ETO fusion protein modules driving CD34+ human progenitor cell expansion

  2018cites this paper
• [Pediatric de novo acute megakaryoblastic leukemia: an affair of complexes].

  2018cites this paper
• Pediatric Acute Megakaryoblastic Leukemia: Multitasking Fusion Proteins and Oncogenic Cooperations.

  2017cites this paper
• ETO2-GLIS2 Hijacks Transcriptional Complexes to Drive Cellular Identity and Self-Renewal in Pediatric Acute Megakaryoblastic Leukemia.

  2017cites this paper
• Suppression of RUNX1/ETO oncogenic activity by a small molecule inhibitor of tetramerization

  2017cites this paper
• EDTA aggregates induce SYPRO orange-based fluorescence in thermal shift assay

  2017cites this paper
• Making the most of hypomethylating agents in myelodysplastic syndromes

  2017cites this paper
• Rigidity Theory-Based Approximation of Vibrational Entropy Changes upon Binding to Biomolecules.

  2017cites this paper
• Design and biological testing of peptidic dimerization inhibitors of human Hsp90 that target the C-terminal domain.

  2016cites this paper
• RUNX1/ETO blocks selectin-mediated adhesion via epigenetic silencing of PSGL-1

  2015cites this paper
• Inhibiting protein-protein interactions in Hsp90 dimerization as a novel approach for targeting cancer

  2015cites this paper
• Complex long-distance effects of mutations that confer linezolid resistance in the large ribosomal subunit

  2015cites this paper
• Re-engineered p53 Activates Apoptosis In Vivo and Causes Primary Tumor Regression in A Dominant Negative Breast Cancer Xenograft Model

  2014cites this paper
• Resolving Hot Spots in the C-Terminal Dimerization Domain that Determine the Stability of the Molecular Chaperone Hsp90

  2014cites this paper
• Pontin is a critical regulator for AML1-ETO-induced leukemia

  2014cites this paper
• Activating c-KIT mutations confer oncogenic cooperativity and rescue RUNX1/ETO-induced DNA damage and apoptosis in human primary CD34+ hematopoietic progenitors

  2014cites this paper
• Predicting and Exploiting the Determinants of Protein/Protein Interactions to Identify Low-Molecular Inhibitors of RUNX1-ETO Tetramerization

  2014cites this paper
• SIAH proteins: critical roles in leukemogenesis

  2013cites this paper
• Structural and Therapeutic Investigations of Human Lipoxygenase

  2013cites this paper
• A chimeric p53 evades mutant p53 transdominant inhibition in cancer cells.

  2013cites this paper
• TAT hitchhiker selection expanded to folding helpers, multimeric interactions and combinations with protein fragment complementation.

  2013cites this paper
• From Determinants of RUNX1/ETO Tetramerization to Small-Molecule Protein-Protein Interaction Inhibitors Targeting Acute Myeloid Leukemia

  2013cites this paper
• Interference with RUNX1/ETO Leukemogenic Function by Cell-Penetrating Peptides Targeting the NHR2 Oligomerization Domain

  2013cites this paper
• Tetramerization Reinforces the Dimer Interface of MnSOD

  2013cites this paper
• Determinants of the species selectivity of oxazolidinone antibiotics targeting the large ribosomal subunit

  2013cites this paper
• Modulating protein-protein interactions: from structural determinants of binding to druggability prediction to application.

  2012cites this paper
• Free Energy Calculations by the Molecular Mechanics Poisson−Boltzmann Surface Area Method

  2012cites this paper
• Caractérisation clinique et moléculaire de nouvelles translocations chromosomiques ciblant le gène RUNX1 dans les leucémies aiguës de l’adulte

  2012cites this paper
• DNA methyltransferase inhibitors in acute myeloid leukemia: discovery, design and first therapeutic experiences

  2012cites this paper
• Hot Spots and Transient Pockets: Predicting the Determinants of Small-Molecule Binding to a Protein-Protein Interface

  2012cites this paper
• ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia.

  2012cites this paper
• Revisiting the differentiation paradigm in acute promyelocytic leukemia.

  2011cites this paper
• Analysis of Leukemogenic Gene Products in Hematopoietic Progenitor Cells

  2011cites this paper
• RUNX1 mutations in clonal myeloid disorders: from conventional cytogenetics to next generation sequencing, a story 40 years in the making.

  2011cites this paper
• Towards targeting protein-protein interfaces with small molecules

  2011cites this paper